AstraZeneca buys CinCor in a deal worth up to $1.8B
AstraZeneca buys CinCor in a deal worth up to $1.8B Published: Jan 09, 2023 By Tristan Manalac BioSpace AstraZeneca has inked a definitive
Tag : Chronic Kidney Disease
Ardelyx’s CKD drug clears FDA adcomm hurdle with 9-4 vote
Ardelyx’s CKD drug clears FDA adcomm hurdle with 9-4 vote Published: Nov 17, 2022 By Alex Keown BioSpace Ardelyx has moved one step closer to the
Life After Diabetes: How A Pancreas Transplant Transformed My Life and Identity
My middle name is Pilgrim. When my parents named me, they never imagined type 1 diabetes (T1D) and life-changing kidney and pancreas transplants
Akebia stands by anemia in CKD drug in dispute resolution request
Akebia stands by anemia in CKD drug in dispute resolution request Published: Nov 07, 2022 By Heather McKenzie BioSpace Akebia Therapeutics is not
16 min read
Novo Nordisk 2022: Expanding capabilities
Supply problems with the weight loss drug Wegovy were a stumbling block to growth, but Novo Nordisk has rallied. By Christiane Truelove
5 min read
Kidney Disease in the Hispanic Population
Sylvia E. Rosas @sylviaerosas Sylvia E. Rosas, MD, MSCE is a nephrologist and epidemiologist at the Joslin Diabetes Center and an Associate Professor
5 min read
Kidney Disease in the Hispanic Population
Sylvia E. Rosas @sylviaerosas Sylvia E. Rosas, MD, MSCE is a nephrologist and epidemiologist at the Joslin Diabetes Center and an Associate Professor
5 min read
Measuring the Success of Advanced Care Planning Implementation in Chronic Kidney Disease Clinics: The Importance of Organizational Readiness
Lachlan McMichael @lachlan_mcm Dr. Lachlan McMichael is a nephrologist & early career clinician-researcher. He is currently undertaking a Kidney
3 min read
Preeclampsia is Not Only a Risk Factor for CKD but Also for Future AKI
Ana Cecilia Farfan Ruiz @AnaCeciliaFarf1 Dr. Ana Cecilia Farfan Ruiz was an AJKD Editorial Intern from 2021-2022. She is currently a renal transplant
4 min read
Preeclampsia is Not Only a Risk Factor for CKD but Also for Future AKI
Ana Cecilia Farfan Ruiz @AnaCeciliaFarf1 Dr. Ana Cecilia Farfan Ruiz was an AJKD Editorial Intern from 2021-2022. She is currently a renal transplant
5 min read
High Sensitivity Troponin and N-terminal Pro-Brain Natriuretic Peptide in Kidney Disease: Personalized Medicine or Renalism?
Raphael Rosen @RaphyRosen Dr. Raphael Rosen was an AJKD Editorial Intern from 2021-2022. A recent graduate of nephrology fellowship at Columbia
1 min read
Charles Ginsberg on Osteoporosis in Advanced Kidney Disease: An Interview
In a recent Review published in AJKD, Charles Ginsberg and Joachim Ix discussed the most recent literature surrounding the diagnosis, management,
1 min read
Charles Ginsberg on Osteoporosis in Advanced Kidney Disease: An Interview
“La Osteoporosis afecta a hombres y mujeres” is by German Tonorio on Flickr. In a recent Review published in AJKD, Charles Ginsberg and Joachim
1 min read
Charles Ginsberg on Osteoporosis in Advanced Kidney Disease: An Interview
In a recent Review published in AJKD, Charles Ginsberg and Joachim Ix discussed the most recent literature surrounding the diagnosis, management,
2 min read
Bayer grabs Chinese okay for CKD therapy Kerendia
On the heels of approvals in the US, Europe and Japan, Bayer’s Kerendia for chronic kidney disease (CKD) associated with type 2 diabetes has been